This includes increased appetite, weight gain, or symptoms of elevated blood sugar
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Here are the expected changes in the medications appearance and the therapeutic outcomes
The membership also does not cover medication costs beyond metformin, shipping fees for some delivery options, or any in-person medical services
Talk with your doctor about how much alcohol, if any, is safe with Bydureon BCise treatment